INIS
adults
8%
assessments
9%
balloons
5%
bladder
88%
cancer
23%
carcinomas
8%
children
5%
comparative evaluations
16%
control
8%
data
13%
devices
9%
diseases
11%
evaluation
8%
females
24%
floors
13%
guidelines
7%
hospitals
6%
humans
5%
implants
7%
injection
5%
interstitials
6%
interventions
7%
levels
5%
males
17%
management
16%
men
17%
muscles
14%
nerves
15%
pain
12%
patients
100%
populations
7%
prostate
21%
quality of life
14%
radiotherapy
6%
recommendations
6%
retention
9%
reviews
27%
risks
9%
safety
9%
stimulation
20%
storage
6%
surgery
25%
symptoms
48%
therapy
20%
toxins
6%
urethra
5%
urinary tract
50%
values
9%
voids
5%
volume
6%
women
17%
Medicine and Dentistry
Adverse Event
6%
Bladder
39%
Bladder Outlet Obstruction
5%
Continence
7%
Cystalgia
6%
Cystectomy
5%
Detrusor
12%
Disease
5%
Diseases
5%
Enuresis
8%
Implant
7%
Incontinence
16%
Interstitial Cystitis
6%
Lower Urinary Tract Symptom
32%
Micturition
5%
Neuromodulation
13%
Neurostimulation
5%
Nocturia
7%
Overactive Bladder
30%
Pelvic Floor
10%
Pelvis
9%
Prevalence
7%
Prostate Cancer
10%
Quality of Life
13%
Randomized Controlled Trial
5%
Sacral Nerve Stimulation
25%
Sensation
5%
Stress Incontinence
18%
Systematic Review
10%
Urinary Retention
7%
Urinary System
5%
Urinary Tract
9%
Urine Incontinence
9%
Urodynamics
12%
Keyphrases
Acute Urinary Retention
5%
Adverse Events
5%
Bladder
21%
Bladder Pain Syndrome
10%
Botulinum Neurotoxin (BoNT)
6%
Detrusor Underactivity
8%
Female Stress Urinary Incontinence
7%
ICI-RS
9%
Incontinence
14%
International Consultation
6%
International Continence Society
5%
Interstitial Cystitis
6%
Lower Urinary Tract
8%
Lower Urinary Tract Symptoms
35%
Netherlands
5%
Neuromodulation
8%
Nocturia
8%
Overactive Bladder Symptom Score (OABSS)
40%
Pelvic Floor Disorders
5%
Pelvic Health
5%
Prostate Cancer
5%
Quality of Life
10%
Sacral Neuromodulation
26%
Stress Urinary Incontinence
10%
Urethral Pressure
5%
Urinary Bladder
5%
Urinary Incontinence
9%
Urodynamic Study
6%
Urodynamics
7%
Ventrolateral Periaqueductal Gray (vlPAG)
5%